Lawrence A. Rosen,
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
4,338
|
|
PDF
|
PDF
|
Metin Colpan,
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
4,243
|
|
PDF
|
PDF
|
Toralf Haag,
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
1,815
|
|
PDF
|
PDF
|
Ross L. Levine,
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
3,803
|
|
PDF
|
PDF
|
Elaine R. Mardis,
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
3,998
|
|
PDF
|
PDF
|
Elizabeth E. Tallett
Supervisory Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
4,487
|
|
PDF
|
PDF
|
Thierry Bernard,
Managing Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
106,903
|
|
PDF
|
PDF
|
Roland Sackers,
Managing Director
|
02/28/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
79,753
|
|
PDF
|
PDF
|
All Supervisory Board Directors 2)
|
02/28/25 Grant
|
Restricted Stock Units
|
5,990
|
|
PDF
|
PDF
|
Thierry Bernard,
Managing Director
|
02/28/25 Grant
|
Performance Stock Units
|
143,229
|
|
PDF
|
PDF
|
Roland Sackers,
Managing Director
|
02/28/25 Grant
|
Performance Stock Units
|
80,098
|
|
PDF
|
PDF
|
Thierry Bernard,
Managing Director
|
02/27/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
434
|
|
PDF
|
PDF
|
Roland Sackers,
Managing Director
|
02/27/25
|
Common Shares
received through release of Restricted Stock Units (“net share settlement”)
|
4,736
|
|
PDF
|
PDF
|
Lawrence A. Rosen,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
415
|
|
PDF
|
PDF
|
Metin Colpan,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
4,910
|
|
PDF
|
PDF
|
Toralf Haag,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
73
|
|
PDF
|
PDF
|
Ross L. Levine,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
465
|
|
PDF
|
PDF
|
Elaine Mardis,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
114
|
|
PDF
|
PDF
|
Elizabeth E.Tallett,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
1,351
|
|
PDF
|
PDF
|
Stephen H. Rusckowski,
Supervisory Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
1
|
|
PDF
|
PDF
|
Thierry Bernard,
Managing Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
8,919
|
|
PDF
|
PDF
|
Roland Sackers,
Managing Director
|
01/28/25
|
Common Shares
(Following the terms of the synthetic share repurchase by QIAGEN N.V., every 36 issued QIAGEN shares were consolidated into 35 QIAGEN shares.)
|
10,951
|
|
PDF
|
PDF
|